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Summary
Validation of the Croatian version of the Asthma Control Test [ACT] in an adult persons with 
asthma was the objective of the study. A total of 90 consecutive asthmatic patients were re-
cruited in a prospective observational study. A pulmonologist blinded to the ACT score assessed 
asthma control according to the Global Initiative for Asthma [GINA] guidelines. Lung function 
was measured and treatment prescribed until the control visit. Seventy-five patients attended the 
control visit after three months, according to the same protocol.
 Two patients had intermittent asthma, 47 patients mild persistent, 31 moderate persistent 
and 10 severe persistent asthma. According to the pulmonologist’s assessment during the first 
examination, 12 patients had uncontrolled asthma, 10 poorly controlled, 47 partially controlled, 
16 well controlled, and 5 completely controlled under the current treatment. The ACT score was 
in the range from 5 points to 25 with mean (SD) score 16.3 [5] and Cronbach α of 0,79 [internal 
validity). ACT score had the best discriminating power for the pulmonologist’s assessment of asth-
ma control (F=17.9; P<0.0001), significantly discriminating uncontrolled, inadequately controlled 
and moderately controlled patients, from well controlled and completely controlled patients. In 
patients attending the control visit, significant correlation was found between the change in ACT 
score and the change in the level of asthma control assessed by the pulmonologist (r2=0.437; 
P<0.001). The results of our study confirmed the validity of the Croatian version of ACT in the 
assessment of disease control in patients with asthma, aged 18-85 years.
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INTRODUCTION
Due to a diminished impact of epidemics in our time and better watering 
with improved living standard, morbidity and mortality has been changed. Many 
chronic non-communicable diseases step on the health stage. Among them a big 
part takes chronic airways diseases, among which are asthma, chronic obstructive 
pulmonary disease (COPD), allergic rhinitis and sleep apnea, with around billion 
persons affected worldwide [1]. Asthma has been fascinating disease for millen-
nia, yet still not enough recognized and treated. At the end of XX. Century the 
comprehensive strategy was establish Global Initiative for Asthma (GINA) [2], with 
the aim to increase awareness about asthma among physicians, health authorities 
and general population, with the purpose for better prevention, diagnostics and 
treatment of asthmatics. Each few years a revised document is publish, every time 
with emphasis on different part of disease management. After more than 10 years of 
using GINA strategy for classification of asthma severity, the revised GINA in year 
2006. stress out asthma control concept. That concept means that the goal of asthma 
treatment is to achieve and maintain clinical control with least dosage medication 
[3]. In revised GINA 2012. the partnership doctor-patient was introduced, while in 
revised GINA strategy 2014. a focus was placed on modifiable risk factors, such as 
smoking, obesity and anxiety. 
Asthma control is assessed by medical history data (incidence of asthma exa-
cerbations), symptoms, lung function, but also assessment of inflammation in ai-
rways (exhaled nitric oxide, or induced sputum [4] and biomarkers, what makes 
asthma assessment complicated, expensive and less available. Physicians need 
simple clinical tool that measure asthma disease status. Several international and 
national guidelines have been developed, including the Croatian one [5], most of 
them recommended usage of questionnaires in the assessment of asthma control. 
Prevalence of asthma in Croatia, is middle high, around 6.9% in children [6]. Occa-
sionally, a differentiation of inadequate asthma control from asthma exacerbation 
is complicated and consequently has occupied the attention of scientists for more 
than a decade [7]. Asthma questionnaires can facilitate decisions about the need 
for treatment modifications (“step up” or “step down”). Studies show that in adult 
patients questionnaires can identify patients who are at risk of asthma exacerbation, 
in need of emergency intervention and hospitalisation [8]. A similar study of a pa-
ediatric population was also published [9]. As a prerequisite for the application of a 
questionnaire in a specific language it is necessary to carry out a validation process. 
Emphasis has recently been placed on the control of asthma [10] and consequently 
we were interested in the extent of the correlation of the Asthma Control Test (ACT) 
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with diagnostic procedures in a specialised pulmonary out-patient department. The 
object of this study was the validation of the Croatian version of the Asthma Control 
Test (ACT) in adult persons with asthma. 
MATERIAL AND METHODS
Study Design and Patients
An observational, prospective, single-centre study was conducted in the Univer-
sity Hospital Centre Zagreb, Clinical Department for Lung Diseases Jordanovac in 
Zagreb, Croatia. The study was carried out from September 1st, up until December 
31st. Consecutive patients attending a routine check-up visit at the Outpatients de-
partment were recruited. Ninety asthmatic patients, aged from 18 to 85 years (mean 
45.3, SD 17.4 years, 50 women (55.6%) were enrolled in the study. All patients were 
required to attend two (physician office) visits, baseline and a scheduled follow-
up (control) visit after three months. During the first visit patients completed the 
ACT and were subject to an interview and clinical examination. In all patients the 
usual measurements of lung function [11] were conducted using forced spirometry 
testing with the flow-volume curve and reversibility testing with salbutamol [12]. 
Spirometry was conducted using computerized apparatus MasterLab Erich Jaeger, 
Wurzburg, Germany, and performed in accordance with the ATS/ERS Guidelines 
[13]. All spirometry measurements were compared with reference values published 
by the European Community for Coal and Steel [14] and expressed as a percentage 
of the predicted values. For reversibility testing, a standardized dose of salbutamol 
was used [4] puffs of 100 mcg with a total administered dose of 400 mcg [15]. Spiro-
metry was repeated at a time when at least 75% of maximal bronchodilator activity 
is expected, after 15 to 30 minutes. A single pulmonologist, with long standing expe-
rience in asthma management, blinded for the ACT responses, rated asthma control 
on a scale from 1 to 5 and asthma severity according to GINA guidelines at both 
visits. Optimal therapy according to GINA guidelines was prescribed according to 
the rated level of control, using “step up” or “step down” approach. Seventy-five pa-
tients (83.0%) attended the control visit after three months and underwent a similar 
procedure as during the baseline visit, with the exclusion of reversibility testing (in-
terview and clinical examination by the pulmonologist, lung function measurement 
and ACT). 
Validation of the ACT was assessed according to internal consistency, test-retest 
reliability, discrimination validity and responsiveness as evidence of change in the 
ACT scores compared to changes in asthma control. The protocol was approved by 
the Local Ethic Committee of the University Hospital for Lung Diseases Jordanovac. 
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All patients provided their written informed consent before being included in the 
study. 
Statistical analysis
Statistical analysis was performed using STATISTICA ver. 6 (StatSoft Inc., Tulsa, 
USA) and MedCalc ver. 9.2.0.1 (MedCalc Software, Mariakerke, Belgium). P=0.05 was 
used as statistically significant for all tests. Mean and SD were used to characterize 
continuous variables and number and percentage (%) for categorical ones. Internal 
consistency of the ACT was assessed using Cronbach α. Test-retest reliability was 
assessed in patients with no change in the level of asthma control .(according to the 
pulmonologist’s assessment between the baseline and control visit, using intraclass 
correlation coefficient (ICC). ANOVA was used to compare continuous variables be-
tween subgroups according to asthma severity and asthma control. Chi-square test 
was used to compare categorical variables between subgroups. Linear regression 
analysis and Spearman rank order correlation were used to calculate the level of 
association between variables. Discriminant analysis and receiver operating char-
acteristic (ROC) curve analysis was used to calculate the area under the ROC curve, 
cut-off value, sensitivity, specificity, positive and negative likelihood ratios (+LR, 
-LR) and diagnostic odds (DO) for ACT in predicting asthma control.
RESULTS
Table 1 shows a description of baseline values for the socio-demographic and 
clinical characteristics of patients recruited in the study. Two (2.2%) patients had 
intermittent, 47 (52.2%) mild persistent, 31 (34.4%) moderate persistent and 10 (11.1%) 
severe persistent asthma. At baseline visit, 12 (13.3%) patients were not controlled, 
10.(11.1%) were poorly controlled, 47 (52.2%) were partially controlled, whila 16 
(17.8%) were well controlled and five (5.5%) were completely controlled. Forty-ni-
ne (54.4%) patients used inhaled corticosteroids in monotherapy, 26 (28.9%) used 
inhaled corticosteroids + long-acting β2-agonists; 18 (20.0%) used leukotriene recep-
tor antagonists, 4 (4.4%) of them used leukotriene receptor antagonists + inhaled 
corticosteroids 5.(5.5%) leukotriene receptor antagonists + inhaled corticosteroids + 
long-acting β2-agonists and 1.(1.1%) leukotriene receptor antagonists + inhaled corti-
costeroids + teophyllin; 6 [6.7%) used just teophyllin; 1 (1.1%) used oral corticosteroid 
therapy and 58 (64.4%) short-acting β2-agonists as needed. The average (SD) forced 
expiratory volume in the first second (FEV1) as a percentage of the predicted value 
was 79.0% (21.1%) and the average reversibility to salbutamol was 16.0% (11.8%, ran-
ge 1.4-64.0%) with a statistically significant inverse correlation to FEV1(%) (r=-0.487; 
Rad za med znan 43 - book 1.indb   42 2.6.2016.   11:45:00
43
Rad 526. Medical Sciences, 43(2016) : 39-49
S. Popović-Grle et al.: Validation of the croatian version of the asthma control test
P<0.001). ACT score rated from 5 points to 25, with a mean [SD) value of 16.3 (5.1) 
points with Cronbach α=0.796 (internal validity) showing high internal consistency. 
The only lung function parameter significantly associated with ACT score was peak 
expiratory flow (PEF) (Spearman R=0.224, P=0.037). ACT showed the best discrimi-
nant capacity for the pulmonologist’s asthma control assessment ( F=23.07; P<0.0001; 
Figure 1) significantly differentiating patients who were not controlled, poorly con-
trolled and partially controlled (non-controlled asthma), from patients who were 
well and completely controlled (controlled asthma) with the area under the ROC 
curve of 0.921(95% CI, 0.868-0.957; P<0.001), sensitivity of 84.3% (95% CI, 74.7-91.4%), 
specificity of 85.0% (95% CI, 75.3-92.0%), +LR 5.62, –LR 0.18 and DO 31.22 for the ACT 
value ≤19 (Figure 2). The addition of  FEV1 (%) to ACT did not contribute to discri-
minant capacity for asthma control assessment (area under the ROC curve 0.895, 
95% CI 0.818-0.971, P>0.05). Out of 75 patients who attended the control visit 7 (9.3%) 
were poorly controlled, 12 (16.0%) partially controlled, 32 (42.7%) well controlled 
and 24 (32.0%) completely controlled. Three patients (4.0%) showed two points poo-
rer asthma control than on the baseline visit, five (6.7 %) one points poorer, fourteen 
(18.7%) showed the same level of control, twenty-two (29.3%) one points better, twen-
ty-one (28.0%) two points better, eight (10.7%) three points better and two (2.7) even 
four points better control. During the control visit FEV1 (%) was 85.5% (SD 19.9) and 
Table 1. Demographic and clinical characteristics of the investigated asthma patients sample 
(N=90)













Gender (%)     Male
         Female
Age, mean (SD), yrs*
Duration of asthma, mean (SD), yrs
% FVC, mean (SD)*
% FEV1, mean (SD)*
% PEF, mean (SD)*
% reversibility of FEV1, mean (SD)
Concomitant conditions (%)




















































Rad za med znan 43 - book 1.indb   43 2.6.2016.   11:45:00
Rad 526. Medical Sciences, 43(2016) : 39-49
S. Popović-Grle et al.: Validation of the croatian version of the asthma control test
44
Figure 2. Plot versus criterion value for asthma control and ACT score (N=90); sensitivity and 
specificity plots with 95% CIs.
Figure 1. Distribution of ACT scores according to the level of asthma control according to 
pulmologist (N=90); 1 - uncontrolled (N=12), 2 - poorly controlled (N=10), 3 - somewhat 
controlled (N=47), 4 - well controlled (N=16), 5 - completely controlled (N=5).
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the average ACT score was 20.7 points (SD 4.2; range 10-25). In patients who atten-
ded the control visit, significant correlation was found between the change in ACT 
score and the change in asthma control assessed by the pulmonologist (Spearman 
R=0.729; P<0,001). In the subgroup of patients in which the same asthma control was 
assessed by the pulmonologist on both visits (N=14) a high level of correspondence 
of the ACT score (ICC=0.864; P<0.001) was found. 
DISCUSSION
A person with asthma in good control has no limitation of productivity or 
physical activity and lead creative life, that why the asthma control is so important. 
Asthma control has been defined as the degree to which the symptoms and activity 
limitation have been prevented, and consequently the step of treatment is adjusted 
according to the level of asthma control achieved [3]. The results of the Asthma 
Insights and Reality in Europe study (AIRE), Asthma in America study (AIA) and 
European Community Respiratory Health survey (ECRHS) showed that despite na-
tional and international guidelines asthma management is suboptimal worldwide 
[18]. No gold standard measure for asthma control was universally accepted. A good 
indicator of asthma control in patients is required usage of rescue medications such 
as short-acting β2-agonists. Patients are often well informed that the frequent usage 
of short-acting β2-agonists is not  recommended,  although few of them are aware of 
the fact that the usage of short-acting β2-agonists of more than once or twice weekly 
is a sign of loss of asthma control [3]. Asthma Control Test is a short patient-based 
5-question survey which does not include pulmonary function tests and has been 
shown to accurately predict the degree of asthma control assessed by the pulmono-
logist on the basis of history, clinical examination and spirometry [10]. We were in-
terested in the ability of the Croatian version of the ACT questionnaire to predict the 
level of asthma control assessed by the expierenced pulmonologist. In patient with 
astma whose astha in uncontrolled or oposite, completelly controlled,  the physician 
interview is short, clinical examination typical, and an asthma specialist can easily 
make a clinical judgement. In our study less than half of patients included in this 
study, examined in the Outpatients Department, were in these categories: twenty-
two (24.4%) were uncontrolled, and 21 (23.3%) patients were well and completely 
controlled on their regular asthma treatment. On the other hand, there is a great 
proportion (47/90) of partially controlled asthmatics in whom more time is needed 
for the clinical interview. It is important to ask the patient about the day- and night-
time symptom frequency, impact of asthma on usual daytime activities, such as 
everyday functining at school or work, interference with sleep, activity limitations, 
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usage of medicines, compliance, education, environment control, asthma emergen-
cy department visits, hospitalisations and comorbidities, particularly symptoms in 
the upper respiratory tract [19]. A comprehensive, lengthy and demanding intervi-
ew is required with most patients in order to precisely estimate asthma control and 
its specific dimensions. This is time consuming even for an asthma specialist, not 
to mention less experienced physicians (general practitioners), and it is debated on 
how to assess control in such a way that it both supports management and simpli-
city of use. In contrast to this consuming time clinical approach, ACT offers  brief, 
but still comprehensive, insight into asthma control which can help to establish the 
level of asthma control, together with its specific dimensions in conjunction with 
the results obtained from other clinical tests. This is also evident from the results of 
our validation study, showing that ACT has a high and significant association with 
the pulmonologist’s evaluation of asthma control. It has been demonstrated that 
ACT predicts asthma control as determined by a specialist evaluation better than 
FEV1, which indicates that control cannot be measured by airway function alone [10, 
20,21), and confirms that specialist assessments are based on more than lung functi-
on measurements. Asthma control is multidimensional in nature, and thus measu-
res of pulmonary function only provide a score in time assessment. In our study the 
addition of FEV1 did not contribute significantly to the discriminant ability of ACT, 
which was consistent with previous reports [21,22), but did contribute marginally 
in the validation study of the original version [10] showing that, although there was 
no significant correlation of ACT score with lung function parameters (apart from a 
very low level with PEF), FEV1 value did not contribute any additional information 
about the level of asthma control that was not already present within the ACT score. 
Almost absent correlation of ACT score with lung function parameters most proba-
bly reflects the multifaceted dimension of asthma control which also depends on 
many other parameters such as underlying inflammation, which is thought to cause 
poor control [23]. The published validation of a Spanish version of ACT, contrary to 
our results, indicates the significance of spirometry in the assessment of asthma pa-
tients and also emphasises that FEV1 should not be used on its own to assess asthma 
control, but in conjunction with clinical assessment [20]. A study in Japan also emp-
hasised the need for multiple measures of control and the significance of measuring 
peek expiratory flow and fractional exhaled nitric oxide (FeNO) in the assessment 
of asthma control in patients in which the ACT score showed complete asthma con-
trol, because the disappearance of symptoms does not mean that the underlining 
inflammation is adequately controlled [21]. Our study shows that ACT correlates 
with complete assessment, including a comprehensive interview by an experienced 
pulmonologist, physical examination and lung function measurement. One of the 
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advantages of this quick and simple tool for the assessment of asthma control is the 
monitoring of patients, so that modulation of treatment is easily recognized. 
Our study showed that the Croatian version of ACT was equally accurate in 
patients with a stable level of control between two consecutive visits and in patients 
in which control was improved or lost. In this respect it allows precise assessment 
of therapeutic interventions, compliance and indication of possible co-morbidities. 
American authors consider that the great value of ACT is in the monitoring of pati-
ents after asthma exacerbation [20], as well as predictors of exacerbation and chan-
ges in therapy [22].
After translation of the international questionnaires to other languages, valida-
tion procedure needs to be conducted. ACT has proved to be very useful in clinical 
practice, which is confirmed by validation of this questionnaire in Europe (Spain) 
[18,21] and in the world (Japan, Singapour) [19, 23]. 
CONCLUSION
After translation of ACT to the Croatian language we conducted validation of 
the Croatian version of ACT in adult patients with asthma and demonstrated that 
the Croatian version of ACT is useful in the assessment of disease control in adult 
patients with asthma.
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Sažetak
Validacija hrvatske inačice testa za kontrolu astme (Asthma Control Test)
U ovoj prospektivnoj opservacijskoj studiji provedena je validacija hrvatske inačice testa za 
kontrolu astme [Asthma Control Test (ACT)] u odraslih osoba s astmom. U istraživanje je uključe-
no 90 susljednih bolesnika s astmom. Pulmolog koji nije znao rezultat ACT testa procjenjivao je 
kontrolu astme u bolesnika prema globalnim smjernicama za astmu [Global Initiative for Asthma 
(GINA)]. Izvedeni su testovi plućne funkcije i preporučeno je liječenje do sljedećeg kontrolnog 
posjeta. U sljedeći kontrolni posjet za tri mjeseca došlo je 75 bolesnika, prema planiranom pro-
tokolu. 
Dvoje bolesnika imalo je povremenu astmu, 47 bolesnika blagu trajnu astmu, 31 umjereno 
tešku trajnu astmu, a 10 bolesnika tešku trajnu astmu. Prema procjeni pulmologa na prvom 
pregledu, 12 bolesnika imalo je nekontroliranu astmu, 10 loše kontroliranu, 47 djelomično kon-
troliranu, 16 dobro kontroliranu, dok je njih 5 imalo astmu potpuno kontroliranu dotadašnjim 
načinom liječenja. ACT rezultat kretao se od 5 do 25 bodova sa srednjim [SD] zbrojem 16.3 [5] 
i Cronbach α od 0,79 [interna validacija]. ACT rezultat imao je najbolju diskriminirajuću snagu 
za pulmološku procjenu kontrole astme [F = 17.9; P < 0.0001] te značajno diskriminirajuću za 
nekontrolirane, djelomično kontrolirane i umjereno kontrolirane bolesnike u odnosu na dobro 
kontrolirane i potpuno kontrolirane bolesnike s astmom. U bolesnika koji su bili u drugome 
kontrolnom posjetu značajna korelacija nađena je između promjene ACT rezultata u odnosu na 
stupanj kontrole astme kako ju je procijenio pulmolog [r2 = 0.437; P < 0.001]. Rezultati ove stu-
dije potvrđuju valjanost hrvatske inačice testa za kontrolu astme ACT u procjeni stupnja kontrole 
bolesti u bolesnika s astmom u dobi između 18 i 85 godina. 
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